January 21, 2016—The House Oversight and Government Reform Committee has subpoenaed former Turing Pharmaceuticals chief executive Martin Shkreli to testify at a Jan. 26 hearing. Shkreli, meanwhile, has invoked the Fifth Amendment in response to a separate Dec. 24 subpoena to produce documents issued by the Senate Select Committee on Aging.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)